Obstetrics/Gynecology
RSSArticles
-
Counsel Women About Contraception Guidelines After Bariatric Surgery
Just-published research indicates that while women should avoid conception for the first 18 months following bariatric surgery, 42% of women participating in the 10-site study reported having unprotected intercourse during the 18-month at-risk, post-surgical timeframe.
-
Research Update: Human Papillomavirus Vaccine Safe for Adult Women
In a study of more than 3 million adult women in Denmark and Sweden, results indicate that human papillomavirus (HPV) vaccination was not connected with 44 serious chronic diseases.
-
Intrauterine Device Use Linked With Decrease in Cervical Cancer Incidence
Results of a just-published systematic review indicate that in women who used an intrauterine device, the incidence of cervical cancer was one-third lower.
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Update on Postpartum Hemorrhage
In the United States, postpartum hemorrhage accounts for 11.4% of maternal deaths, the fourth most common cause after cardiovascular diseases, non-cardiovascular diseases, and infection; worldwide, it is the leading cause of maternal mortality. This feature will discuss the latest treatments for managing postpartum hemorrhage.
-
Hormone Replacement: Have We Made Progress Since WHI?
Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.
-
Trends in OB/GYN Malpractice Litigation
In this review of medicolegal claims data from 2005-2014, obstetric and gynecologic surgery had the second highest average indemnity payment compared to other specialties, topped only by neurosurgery. Of the 10,915 claims identified, the majority (60%) were dropped, withdrawn, or dismissed; 31.1% of claims were paid by the defendant (90% before trial); and 7.5% were successfully defended by the physician.
-
New Treatment Option for Women at Risk of Fragility Fractures
A randomized trial demonstrated a reduced risk of fragility fractures in high-risk women with osteoporosis treated monthly with the monoclonal antibody romosozumab compared with weekly alendronate.
-
Science Focuses on Mycoplasma genitalium
Mycoplasma genitalium, a sexually transmitted infection, is a major cause of urethritis in men and is associated with cervicitis, pelvic inflammatory disease, preterm birth, and spontaneous abortion in women.
-
New Study Points to Long-term Effectiveness of 9-Valent HPV Vaccine
Vaccine could prevent 90% of cervical cancer cases worldwide.